- Home
- CLMT vs SIGA Comparison
CLMT vs SIGA Comparison
Compare CLMT & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLMT
- SIGA
- Stock Information
- Founded
- CLMT 1916
- SIGA 1995
- Country
- CLMT United States
- SIGA United States
- Employees
- CLMT N/A
- SIGA N/A
- Industry
- CLMT Oil & Gas Production
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- CLMT Energy
- SIGA Health Care
- Exchange
- CLMT Nasdaq
- SIGA Nasdaq
- Market Cap
- CLMT 1.3B
- SIGA 422.9M
- IPO Year
- CLMT 2006
- SIGA 1997
- Fundamental
- Price
- CLMT $16.78
- SIGA $6.77
- Analyst Decision
- CLMT Strong Buy
- SIGA
- Analyst Count
- CLMT 6
- SIGA 0
- Target Price
- CLMT $20.17
- SIGA N/A
- AVG Volume (30 Days)
- CLMT 1.5M
- SIGA 382.0K
- Earning Date
- CLMT 08-08-2025
- SIGA 07-31-2025
- Dividend Yield
- CLMT N/A
- SIGA 8.70%
- EPS Growth
- CLMT N/A
- SIGA N/A
- EPS
- CLMT N/A
- SIGA 0.67
- Revenue
- CLMT $4,177,500,000.00
- SIGA $120,330,310.00
- Revenue This Year
- CLMT N/A
- SIGA N/A
- Revenue Next Year
- CLMT N/A
- SIGA $95.31
- P/E Ratio
- CLMT N/A
- SIGA $10.28
- Revenue Growth
- CLMT 0.68
- SIGA N/A
- 52 Week Low
- CLMT $7.68
- SIGA $4.95
- 52 Week High
- CLMT $25.29
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- CLMT 63.02
- SIGA 61.28
- Support Level
- CLMT $15.63
- SIGA $6.34
- Resistance Level
- CLMT $17.13
- SIGA $7.07
- Average True Range (ATR)
- CLMT 0.73
- SIGA 0.22
- MACD
- CLMT -0.03
- SIGA 0.02
- Stochastic Oscillator
- CLMT 83.87
- SIGA 71.70
About CLMT Calumet Specialty Products Partners L.P. Common Units
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.